Plain-English translation of NCT06561932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the WiSE CRT System, a new type of implantable heart device that helps coordinate your heart's rhythm without using traditional wires (called leads). The system works by placing small pacemakers inside your heart chambers to help them beat together more effectively. This approach may be helpful if you have heart failure and want to avoid lifelong surgery to manage traditional lead-based pacemakers.
Many people with heart failure benefit from devices that coordinate the heart's rhythm, but traditional systems require wires that can fail or cause infections over a lifetime. This trial exists to see if a totally leadless approach can work safely and effectively, potentially avoiding these long-term complications.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo surgery to have the WiSE CRT System implanted in your heart. After the implant, you will take part in regular follow-up visits where doctors will check how well the device is working and monitor your heart failure symptoms. You will continue taking your regular heart failure medications alongside the device therapy.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Australia